I love working with companies as they grow – learning about the work they do and getting to know the people who turn great ideas into reality.
kkazem@cooley.com
Katie Kazem's practice focuses on corporate and securities law and includes the general representation of both public and private companies. She has experience working on M&A, public offerings and venture capital financings.
Download full bio
AvePoint to Combine With Apex Technology, a Special Purpose Acquisition Company, at $2 Billion Value
AppHarvest to Combine With Novus Capital, a Special Purpose Acquisition Company
RenalytixAI – $85 Million IPO
Innate Pharma - $79 Million IPO
Genfit - $155 Million IPO
View all
Public Companies
Mergers & Acquisitions
Capital Markets
Painting
Reading
Running
George Mason University School of LawJD, magna cum laude, 2010
George Mason University School of Public PolicyMA, 2007
College of William & MaryBA, GovernmentMonroe Scholar, 2003
Virginia
District of Columbia
AvePoint to Combine With Apex Technology, a Special Purpose Acquisition Company, at $2 Billion Value February 16, 2021
AppHarvest to Combine With Novus Capital, a Special Purpose Acquisition Company September 29, 2020
Autolus – $173 Million IPO July 9, 2018
+1 703 456 8043
Locations